John Willan
Impact in
-
- Venous Thromboembolism Diagnosis and Management
-
- COVID-19 and healthcare impacts
Papers in
- Oncology 6
- COVID-19 and healthcare impacts 4
-
- Protein Degradation and Inhibitors 2
- Sexual Differentiation and Disorders 2
- Co-authors
- Andrew J. King (2 shared papers)Nicola Bienz (2 shared papers)Katie Jeffery (1 shared paper)Graham P. Collins (3 shared papers)Andrew Peniket (1 shared paper)Harley Katz (2 shared papers)David Keeling (1 shared paper)Rowan Diamond (1 shared paper)
- Journals
- British Journal of Haematology (5 papers)European Journal Of Haematology (2 papers)BMJ (1 paper)PLoS ONE (1 paper)Developmental Dynamics (1 paper)
- Partner nations
- United KingdomAustralia
In The Last Decade
John Willan
12 papers receiving 403 citations
Peers
Comparison fields: 5 of 84
- Internal Medicine 18
- Oncology 132
- Infectious Diseases 66
- Hematology 40
- Emergency Medical Services 20
Countries citing papers authored by John Willan
This map shows the geographic impact of John Willan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Willan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Willan more than expected).
Fields of papers citing papers by John Willan
This network shows the impact of papers produced by John Willan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Willan. The network helps show where John Willan may publish in the future.
Co-authors
The 25 scholars most cited alongside John Willan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 178 | |
| 2 | 2020 | 58 | |
| 3 | 2016 | 32 | |
| 4 | 2019 | 30 | |
| 5 | 2020 | 29 | |
| 6 | 2003 | 23 | |
| 7 | 2020 | 20 | |
| 8 | 2020 | 15 | |
| 9 | 2023 | 11 | |
| 10 | 2008 | 8 | |
| 11 | 2020 | 3 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 0 |
About John Willan
John Willan is a scholar working on Oncology, Molecular Biology, Infectious Diseases, General Health Professions and Hematology, having authored 13 papers that have together received 408 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (4 papers), COVID-19 Clinical Research Studies (3 papers), Healthcare cost, quality, practices (3 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (2 papers), Protein Degradation and Inhibitors (2 papers), Multiple Myeloma Research and Treatments (2 papers), Sexual Differentiation and Disorders (2 papers) and Psychological Well-being and Life Satisfaction (1 paper). The work is most often cited by research in Internal Medicine (18 citations), Oncology (132 citations), Infectious Diseases (66 citations), Hematology (40 citations) and Emergency Medical Services (20 citations). John Willan has collaborated with scholars based in United Kingdom and Australia. Frequent co-authors include Andrew J. King, Nicola Bienz, Katie Jeffery, Graham P. Collins, Andrew Peniket, Harley Katz, David Keeling, Rowan Diamond, Toby A. Eyre and Karthik Ramasamy. Their work appears in journals such as British Journal of Haematology, European Journal Of Haematology, BMJ, PLoS ONE and Developmental Dynamics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.